NCT04086485

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

RecruitingPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2022-10-03Est. Completion: 2027-07-01

Enrollment target: 56 participants

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Contact

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.